These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12223955

  • 21. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology.
    Dueker DK, Singh K, Lin SC, Fechtner RD, Minckler DS, Samples JR, Schuman JS.
    Ophthalmology; 2007 Sep; 114(9):1779-87. PubMed ID: 17822980
    [Abstract] [Full Text] [Related]

  • 22. Clinical comparison of pascal dynamic contour tonometry and goldmann applanation tonometry in asymmetric open-angle glaucoma.
    Sullivan-Mee M, Halverson KD, Qualls C.
    J Glaucoma; 2007 Dec; 16(8):694-9. PubMed ID: 18091457
    [Abstract] [Full Text] [Related]

  • 23. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G, Bozkurt B, Irkec M.
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [Abstract] [Full Text] [Related]

  • 24. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG, Komaroff E, Heijl A, Bengtsson B, Leske MC, Early Manifest Glaucoma Trial Group.
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [Abstract] [Full Text] [Related]

  • 25. [Clinical efficacy of 0.2% brimonidine in patients with open-angle glaucoma or ocular hypertension].
    Shi JM, Jiang YQ.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun 28; 27(3):263-6. PubMed ID: 12575311
    [Abstract] [Full Text] [Related]

  • 26. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B, Leske MC, Hyman L, Heijl A, Early Manifest Glaucoma Trial Group.
    Ophthalmology; 2007 Feb 28; 114(2):205-9. PubMed ID: 17097736
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.
    Ann Pharmacother; 2008 Apr 28; 42(4):498-504. PubMed ID: 18364402
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.
    Wanichwecha-Rungruang B, Iemsomboon W.
    J Med Assoc Thai; 2005 Sep 28; 88(9):1228-35. PubMed ID: 16536109
    [Abstract] [Full Text] [Related]

  • 29. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL, Bimatoprost Study Group.
    Br J Ophthalmol; 2008 Oct 28; 92(10):1387-92. PubMed ID: 18621791
    [Abstract] [Full Text] [Related]

  • 30. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage.
    Jonas JB, Stroux A, Martus P, Budde W.
    J Glaucoma; 2006 Jun 28; 15(3):206-12. PubMed ID: 16778642
    [Abstract] [Full Text] [Related]

  • 31. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.
    European Glaucoma Prevention Study (EGPS) GroupUniversità di Milano Bicocca, Policlinico di Monza, Via Amati 111, 20052, Monza, Mi, Italy. stefano.miglior@unimib.it, Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I.
    Ophthalmology; 2007 Jan 28; 114(1):3-9. PubMed ID: 17070596
    [Abstract] [Full Text] [Related]

  • 32. Health care charges for patients with ocular hypertension or primary open-angle glaucoma.
    Pasquale LR, Dolgitser M, Wentzloff JN, Stern LS, Doyle JJ, Chiang TH, Walt JG.
    Ophthalmology; 2008 Apr 28; 115(4):633-638.e4. PubMed ID: 17716736
    [Abstract] [Full Text] [Related]

  • 33. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, EMGT Group.
    Ophthalmology; 2007 Nov 28; 114(11):1965-72. PubMed ID: 17628686
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness of treating ocular hypertension.
    Stewart WC, Stewart JA, Nasser QJ, Mychaskiw MA.
    Ophthalmology; 2008 Jan 28; 115(1):94-8. PubMed ID: 18166406
    [Abstract] [Full Text] [Related]

  • 35. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar 28; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 36. Lifetime visual disability in open-angle glaucoma and ocular hypertension.
    Forsman E, Kivelä T, Vesti E.
    J Glaucoma; 2007 May 28; 16(3):313-9. PubMed ID: 17438426
    [Abstract] [Full Text] [Related]

  • 37. Development of a prediction rule to estimate the probability of acceptable intraocular pressure reduction after selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension.
    Mao AJ, Pan XJ, McIlraith I, Strasfeld M, Colev G, Hutnik C.
    J Glaucoma; 2008 Sep 28; 17(6):449-54. PubMed ID: 18794678
    [Abstract] [Full Text] [Related]

  • 38. Trabeculotomy combined with phacoemulsification and implantation of intraocular lens for primary open-angle glaucoma.
    Mizoguchi T, Kuroda S, Terauchi H, Nagata M.
    Semin Ophthalmol; 2001 Sep 28; 16(3):162-7. PubMed ID: 15513436
    [Abstract] [Full Text] [Related]

  • 39. Management of patients with ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
    Rosenbaum LJ.
    Am J Ophthalmol; 2007 Jan 28; 143(1):191-2; author reply 192-3. PubMed ID: 17188074
    [No Abstract] [Full Text] [Related]

  • 40. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J, Coleman AL.
    Ophthalmology; 2008 Jul 28; 115(7):1123-1129.e3. PubMed ID: 18082889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.